|
1
|
Sharma S, Awasthi A and Singh S: Altered
gut microbiota and intestinal permeability in Parkinson's disease:
Pathological highlight to management. Neurosci Lett.
712(134516)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nair AT, Ramachandran V, Joghee NM, Antony
S and Ramalingam G: Gut microbiota dysfunction as reliable
non-invasive early diagnostic biomarkers in the pathophysiology of
Parkinson's disease: A critical review. J Neurogastroenterol Motil.
24:30–42. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Xu X, Wang R, Hao Z, Wang G, Mu C, Ding J,
Sun W and Ren H: DJ-1 regulates tyrosine hydroxylase expression
through CaMKKβ/CaMKIV/CREB1 pathway in vitro and in vivo. J Cell
Physiol. 235:869–879. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yin C, Deng Y, Liu Y, Gao J, Yan L and
Gong Q: Icariside II ameliorates cognitive impairments induced by
chronic cerebral hypoperfusion by inhibiting the amyloidogenic
pathway: Involvement of BDNF/TrkB/CREB signaling and up-regulation
of PPARα and PPARγ in rats. Front Pharmacol. 9(1211)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Deng Y, Xiong D, Yin C, Liu B, Shi J and
Gong Q: Icariside II protects against cerebral ischemia-reperfusion
injury in rats via nuclear factor-κB inhibition and peroxisome
proliferator-activated receptor up-regulation. Neurochem Int.
96:56–61. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yan BY, Pan CS, Mao XW, Yang L, Liu YY,
Yan L, Mu HN, Wang CS, Sun K, Liao FL, et al: Icariside II improves
cerebral microcirculatory disturbance and alleviates hippocampal
injury in gerbils after ischemia-reperfusion. Brain Res.
1573:63–73. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yin C, Deng Y, Gao J, Li X, Liu Y and Gong
Q: Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates
streptozotocin-induced cognitive deficits in rats. Neuroscience.
328:69–79. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Deng Y, Long L, Wang K, Zhou J, Zeng L, He
L and Gong Q: Icariside II, a broad-spectrum anti-cancer agent,
reverses beta-amyloid-induced cognitive impairment through reducing
inflammation and apoptosis in rats. Front Pharmacol.
8(39)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiao HH, Chen JC, Li H, Li RH, Wang HB,
Song HP, Li HY, Shan GS, Tian Y, Zhao YM, et al: Icarisid II
rescues cognitive dysfunction via activation of Wnt/β-catenin
signaling pathway promoting hippocampal neurogenesis in APP/PS1
transgenic mice. Phytother Res. 36:2095–2108. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Yan L, Deng Y, Gao J, Liu Y, Li F, Shi J
and Gong Q: Icariside II effectively reduces spatial learning and
memory impairments in Alzheimer's disease model mice targeting
beta-amyloid production. Front Pharmacol. 8(106)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Gu Z, Lin S, Chen L, Dzreyan V, Eid
M, Demyanenko S and He B: Histone deacetylases as epigenetic
targets for treating Parkinson's disease. Brain Sci.
12(672)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ma P and Schultz RM: HDAC1 and HDAC2 in
mouse oocytes and preimplantation embryos: Specificity versus
compensation. Cell Death Differ. 23:1119–1127. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Stoddard SV, May XA, Rivas F, Dodson K,
Vijayan S, Adhika S, Parker K and Watkins DL: Design of potent
panobinostat histone deacetylase inhibitor derivatives: Molecular
considerations for enhanced isozyme selectivity between HDAC2 and
HDAC8. Mol Inform. 38(e1800080)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen J, Li N, Liu B, Ling J, Yang W, Pang
X and Li T: Pracinostat (SB939), a histone deacetylase inhibitor,
suppresses breast cancer metastasis and growth by inactivating the
IL-6/STAT3 signalling pathways. Life Sci.
248(117469)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan Y, Delvaux E, Nolz J, Coleman PD, Chen
S and Mastroeni D: Upregulation of histone deacetylase 2 in laser
capture nigral microglia in Parkinson's disease. Neurobiol Aging.
68:134–141. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Choong CJ, Sasaki T, Hayakawa H, Yasuda T,
Baba K, Hirata Y, Uesato S and Mochizuki H: A novel histone
deacetylase 1 and 2 isoform-specific inhibitor alleviates
experimental Parkinson's disease. Neurobiol Aging. 37:103–116.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Singer TP and Ramsay RR: Mechanism of the
neurotoxicity of MPTP. An update. FEBS Lett. 274:1–8.
1990.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yuan X, Wu Y, Lu L and Feng J: Long
noncoding RNA SNHG14 knockdown exerts a neuroprotective role in
MPP+-induced Parkinson's disease cell model through
mediating miR-135b-5p/KPNA4 axis. Metab Brain Dis. 37:2363–2373.
2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xu F, Lv C, Deng Y, Liu Y, Gong Q, Shi J
and Gao J: Icariside II, a PDE5 inhibitor, suppresses
oxygen-glucose deprivation/reperfusion-induced primary hippocampal
neuronal death through activating the PKG/CREB/BDNF/TrkB signaling
pathway. Front Pharmacol. 11(523)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Halczuk KM, Boguszewska K, Urbaniak SK,
Szewczuk M and Karwowski BT: 8-oxo-7,8-dihydro-2'-deoxyguanosine
(8-oxodG) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) as a cause of
autoimmune thyroid diseases (AITD) during pregnancy? Yale J Biol
Med. 93:501–515. 2020.PubMed/NCBI
|
|
22
|
Perelman A, Wachtel C, Cohen M, Haupt S,
Shapiro H and Tzur A: JC-1: Alternative excitation wavelengths
facilitate mitochondrial membrane potential cytometry. Cell Death
Dis. 3(e430)2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jiang DQ, Ma YJ, Wang Y, Lu HX, Mao SH and
Zhao SH: Microglia activation induces oxidative injury and
decreases SIRT3 expression in dopaminergic neuronal cells. J Neural
Transm (Vienna). 126:559–568. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Harrington JS, Ryter SW, Plataki M, Price
DR and Choi AMK: Mitochondria in health, disease, and aging.
Physiol Rev. 103:2349–2422. 2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Golpich M, Amini E, Mohamed Z, Azman Ali
R, Mohamed Ibrahim N and Ahmadiani A: Mitochondrial dysfunction and
biogenesis in neurodegenerative diseases: Pathogenesis and
treatment. CNS Neurosci Ther. 23:5–22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Grimm A and Eckert A: Brain aging and
neurodegeneration: From a mitochondrial point of view. J Neurochem.
143:418–431. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Park JS, Davis RL and Sue CM:
Mitochondrial dysfunction in Parkinson's disease: New mechanistic
insights and therapeutic perspectives. Curr Neurol Neurosci Rep.
18(21)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kim HY, Bae CH, Kim J, Lee Y, Jeon H, Kim
H and Kim S: Rumex japonicus houtt. protects dopaminergic neurons
by regulating mitochondrial function and gut-brain axis in in vitro
and in vivo models of Parkinson's disease. Antioxidants (Basel).
11(141)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu LK, Agarwal S, Kuo CH, Kung YL, Day CH,
Lin PY, Lin SZ, Hsieh DJ, Huang CY and Chiang CY: Artemisia leaf
extract protects against neuron toxicity by TRPML1 activation and
promoting autophagy/mitophagy clearance in both in vitro and in
vivo models of MPP+/MPTP-induced Parkinson's disease.
Phytomedicine. 104(154250)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu Y, Wang Y, Chen Q, Jiao F, Wang L and
Gong Z: HDAC2 inhibitor CAY10683 reduces intestinal epithelial cell
apoptosis by inhibiting mitochondrial apoptosis pathway in acute
liver failure. Histol Histopathol. 34:1173–1184. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Frankowski H, Yeboah F, Berry BJ,
Kinoshita C, Lee M, Evitts K, Davis J, Kinoshita Y, Morrison RS and
Young JE: Knock-down of HDAC2 in human induced pluripotent stem
cell derived neurons improves neuronal mitochondrial dynamics,
neuronal maturation and reduces amyloid beta peptides. Int J Mol
Sci. 22(2526)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Y, Feng L, Xie D, Lin M, Li Y, Chen N,
Yang D, Gao J, Zhu Y and Gong Q: Icariside II, a naturally
occurring SIRT3 agonist, protects against myocardial infarction
through the AMPK/PGC-1α/apoptosis signaling pathway. Antioxidants
(Basel). 11(1465)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Feng L, Gao J, Liu Y, Shi J and Gong Q:
Icariside II alleviates oxygen-glucose deprivation and
reoxygenation-induced PC12 cell oxidative injury by activating
Nrf2/SIRT3 signaling pathway. Biomed Pharmacother. 103:9–17.
2018.PubMed/NCBI View Article : Google Scholar
|
